Why KKR & Co. Inc (KKR) Should Be On Your Radar Moving Forward
KKR & Co. Inc (NYSE:KKR) shares traded -3.00% lower at $119.75 on Wall Street last session. KKR stock price is now 9.76% away from the 50-day moving average and 31.41% away from the 200-day moving average. The market capitalization of the company currently stands at $106.27B. With the price target of $96, TD Cowen recently […]
Despite Metlife Inc [MET]’s great opportunity, the stock is a bit overvalued
The price of Metlife Inc (NYSE:MET) shares last traded on Wall Street fell -1.39% to $75.78. MET stock price is now 5.24% away from the 50-day moving average and 10.16% away from the 200-day moving average. The market capitalization of the company currently stands at $53.89B. With the price target maintained at $80, Goldman recently […]
Stocks of FibroGen Inc [FGEN] are gaining investors’ attention: here’s why
In yesterday’s Wall Street session, FibroGen Inc (NASDAQ:FGEN) shares traded at $0.47, down -12.98% from the previous session. FGEN stock price is now -56.45% away from the 50-day moving average and -60.18% away from the 200-day moving average. The market capitalization of the company currently stands at $46.76M. With the price target reduced from $4 […]
Is Teradyne, Inc. [TER] a good investment? Don’t be fooled by its recent momentum
In yesterday’s Wall Street session, Teradyne, Inc. (NASDAQ:TER) shares traded at $121.74, down -7.18% from the previous session. TER stock price is now -16.33% away from the 50-day moving average and 7.42% away from the 200-day moving average. The market capitalization of the company currently stands at $19.00B. With the price target maintained at $124, […]
Rithm Capital Corporation [RITM] attracts people because of its fundamentals
Rithm Capital Corporation (NYSE:RITM) shares traded -2.24% lower at $11.35 on Wall Street last session. RITM stock price is now 1.91% away from the 50-day moving average and 5.93% away from the 200-day moving average. The market capitalization of the company currently stands at $5.49B. With the price target of $12.50, UBS recently initiated with […]
Stocks like Royalty Pharma plc [RPRX] still have plenty of sunny days ahead
Stocks of Royalty Pharma plc (NASDAQ:RPRX) traded higher last session on Wall Street, up 1.14% to $28.49. RPRX stock price is now 5.09% away from the 50-day moving average and 1.11% away from the 200-day moving average. The market capitalization of the company currently stands at $12.88B. With the price target maintained at $28, UBS […]
Is Dominion Energy Inc (NYSE:D) being unfairly punished by investors?
The price of Dominion Energy Inc (NYSE:D) shares last traded on Wall Street rose 3.70% to $55.44. D stock price is now 8.04% away from the 50-day moving average and 15.30% away from the 200-day moving average. The market capitalization of the company currently stands at $46.47B. With the price target enhanced from $43 to […]
The most important numbers to know about Gen Digital Inc (NASDAQ:GEN)
The stock of Gen Digital Inc (NASDAQ:GEN) last traded at $25.24, down -2.89% from the previous session. GEN stock price is now 1.46% away from the 50-day moving average and 13.66% away from the 200-day moving average. The market capitalization of the company currently stands at $15.53B. With the price target reduced from $28 to […]
Duke Energy Corp. (NYSE:DUK) Risks You Should Know Before Investing
In yesterday’s Wall Street session, Duke Energy Corp. (NYSE:DUK) shares traded at $112.60, up 3.05% from the previous session. DUK stock price is now 8.99% away from the 50-day moving average and 16.40% away from the 200-day moving average. The market capitalization of the company currently stands at $86.90B. With the price target reduced from […]
Before Investing In Gates Industrial Corporation plc (NYSE:GTES), Here Are Some Things To Consider
Gates Industrial Corporation plc (NYSE:GTES) shares traded -4.57% lower at $17.74 on Wall Street last session. GTES stock price is now 6.41% away from the 50-day moving average and 19.86% away from the 200-day moving average. The market capitalization of the company currently stands at $4.64B. With the price target maintained at $20, Wolfe Research […]
